Delivery Order SPE2DB22D1017-SPE2DB25FG4CG
Award Date
6/3/25
Potential Completion Date
6/4/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,488.44 and an ultimate completion date of November 14, 2024. It is a Firm Fixed Price delivery order contract awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $8,001.99. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
This federal contract award is for the provision of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,709.46 and an ultimate completion date of December 30, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of the pharmaceutical product Dupixent (300 mg/2 ml syringe, 2 ml) to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $13,675.68 and an ultimate completion date of December 3, 2024. It was awarded on December 2,...
This federal contract award is for the supply of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA), a defense agency. The prime contractor, Amerisourcebergen Drug Corp, holds an Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The awarded...
The federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,966.22 and is a firm fixed-price delivery order with a completion date of December 19, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
The federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to support the Defense Logistics Agency (DLA) Troop Support Medical program. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA for providing a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,972.11 and a completion date of March 27, 2024. It is a Firm Fixed Price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
The federal contract award details a delivery order for Dupixent 300 mg/2 ml syringes valued at $2,441.35. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on July 12, 2024. The contract has a firm fixed price and an ultimate completion date of July 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml syringe, 2 ml, with a ceiling value of $13,531.42. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 23, 2024 and is a delivery order with a firm fixed price pricing type. The contract is not designated as a set-aside and represents an award...